EUVIMEDEUVIMED entdecken
Crossref

Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors

New Materials, Compounds and Applications · 03.04.2026

DOI: 10.62476/nmca.10165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Materials, Compounds and Applications, online erschienen am 03.04.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors. New Materials, Compounds and Applications. https://doi.org/10.62476/nmca.10165

Vancouver

Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors. New Materials, Compounds and Applications. 2026. doi:10.62476/nmca.10165

BibTeX
@article{euvimed2026,
  title = {Computational Assessment and Molecular Docking of Arylhydrazone Ester Derivatives as SARS-CoV-2 Main Protease Inhibitors},
  journal = {New Materials, Compounds and Applications},
  year = {2026},
  doi = {10.62476/nmca.10165}
}
Kostenlos starten →